Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma

Cancer Biochemistry Biophysics

Volumn 16, Issue 3, 1998, Pages 213-227

  Paltoo, Dina N ^a   Canada, Robert G ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cisplatin; FaDu cells; Terbium

Indexed keywords

EID: 0032194406     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Andrews P A. (1994). Mechanisms of acquired resistance to cisplatin. L. J. Goldstein and R. F. Ozols, (Eds.). Anticancer drug resistance: Advances in molecular and clinical research. Kluwer Academic Publishers. Boston. 217-248.
2. Awasthi S., R. Sharma, S. S. Singhal, N. K. Herzog, M. Chaubey and Y. C Awasthi (1994). Modulation of cisplatin cytotoxicity by sulphasalazine. Br. J. Cancer. 70, 190-194.
3. Barela T. D., and A D.Sherry (1976). A simple, on-step fluorometric method for determination of nanomolar concentrations of terbium. An. Biochem. 71, 351-357.
4. Bohinski R. C (1987). Modern Concepts in Biochemistry, fifth edition Allyn and Bacon. Inc. Boston.
5. Canada R. G. (1983) Terbium binding to neoplastic GH3 pituitary cells. Biochem. Biophys. Res. Com. 111, 135-142
6. Canada R. G. (1986). Terbium fluorescence studies of cisplatin binding to GH3/B6 pituitary tumor cells. Biochim. Biophys. Acta. 887, 29-34
7. Canada R G. (1993). Calcium receptor binding of cisplatin and terbium in human breast tumor cells after hyperthermia Rad. Res. 133, 170-175.
8. Canada R. G., P. A. Andrews, K. M. Mack, and A. Haider (1995). The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells. Biochim. Biophys. Acta. 1267, 25-30.
9. Canada R G and D. N. Paltoo (1996). Time-resolved terbium luminescence studies of the calcium receptor binding of cisplatin in human ovarian cancer cells. Biophys. J. 70, A211.
10. Chou J. and T-C. Chou (1988). Dose-effect analysis with microcomputers. Elsevier-Biosoft, Cambridge, U. K
11. Chou T-C. and P. Talalay (1984). Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27-55
12. Chyou P. H., A. M. Y. Nomura and G. N. Stemmerman (1995). Diet, alcohol, smoking and cancer of the upper aerodigestive tract: a prospective study among Hawaii Japanese men Int. J. Cancer 60, 616-621.
13. Dewitt L. (1987). Combined treatment of radiation and cis-diamminedichloroplatinum (II): a review of experimental and clinical data. Int. J. Rad. Oncol. Biol. Phys. 13, 403-426.
14. Evans C. H. (1990). Biochemistry of the Lanthanides. Plenum Press, New York.
15. Gately D. P. and S B. Howell (1993). Cellular accumulation of the anticancer agent cisplatin: a review. Br J. Cancer 87, 1171-1176.
16. Harris D. A. and C L. Bashford (1987). Spectrophotometry and spectrofluorimetry a practical approach. IRL Press, Oxford.
17. Jekunen A. P., D R. Shalinsky, D. K. Hom, K. D. Albright, D. Heath and S. B. Howell (1993). Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem. Pharmacol. 45, 2079-2085.
18. Krause C. J., T. E. Carey, R. W. Ott, C. Hurbus, K. D McClatchey and J. A. Regezi (1981). Human squamous cell carcinoma. Arch. Otolryngol. 107, 703-710.
19. Lakowicz J R (1983). Principles of Fluorescence Spectroscopy. Plenum Press. New York.
20. Levinson C., T. M. Mikiten, and T. C Smith (1972). Lanthanum-induced alterations in cellular electrolytes and membrane potential in ehrlich ascites tumor cells. J. Cell Physiol. 79, 299-308.
21. Mack K M , R. G. Canada and P. A. Andrews (1997) The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells. Cancer Chemother. Pharmacol 39, 217-222.
22. Martin R. B. and F. S. Richardson (1979). Lanthanides as probes for calcium in biological systems Quarterly Rev Biophys. 12, 181-209.
23. McGuire W. P., W. J Hoskins, M. F. Brady, P. R Kucera, E. E Partridge, K. Y. Look, D. L. Clarke-Pearson and M. Davidson (1996). Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. New Eng. J. Med. 334, 1-6.
24. Millelson R. B (1976). Lanthanides as calcium probes in biomembranes. Biol Memb. 3, 158-190.
25. Nehme A., A. M Julia, S. Jozan, C. Chevreau, R. Bugat and P. Canal (1994) Modulation of cisplatin cytotoxicity by human recombinant interferon-γ in human ovarian cancer cell lines Eur. J. Cancer. 30A, 520-525.
26. Onoda J. M., J. R. Jacobs, J. D. Taylor, B. F. Sloane and K. V. Honn (1986). Cisplatin and nifedipine: Synergistic cytotoxicity against murine solid tumors and their metastases. Cancer Lett. 30, 181-188
27. Onoda J M., K K. Nelson, J. D. Taylor and K V. Honn (1989). In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cisdiamminedichloroplatinum (II) Cancer Res. 49, 2844-2850.
28. Paltoo D N. and R. G. Canada (1996) Calcium receptor binding of terbium and survival of human head and neck cancer cells after hyperthermia. FASEB J. 10, A666
29. Rangan S. R. S. (1972). A new human cell line (FaDu) from a hypopharyngcal carcinoma. Cancer. 29, 117-121.
30. Reed E and K. W. Kohn (1990). B. A Chabner (Ed.) Platinum Analogues: Chemotherapy Principles and Practice, Academic Press Inc. , New York, pp 465-490.
31. Rosenberg B (1985) Fundamental studies with cisplatin (1985). Cancer. 55, 2303-2316.
32. Saito T , R. Moataz and D. Dulon (1991). Cisplatin blocks depolarization-induced calcium entry in isolated cochlear outer hair cells. Hearing. Res. 56, 143-147.
33. Segel I. H. (1975) Enzyme kinetics: Behavior and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley & Sons, New York.
34. Simpkins H., M. Figliomeni and M. Rosen (1988). The interaction of platinum and anthrapyrazole antitumor drugs with mouse thymocytes studied by terbium fluorescence. Biochim. Biophys. Acta. 972, 25-32.
35. Timmer-Bosscha H., N. H. Mulder and E. G E. de Vries (1992). Modulation of cisdiamminedichloroplatinum(II) resistance: a review. Br. J Cancer 66, 227-238.
36. Winn D M (1995) Diet and nutrition in the etiology of oral cancer. Amer J. Clin. Nutr. 61, 437S-445S
37. Yamamoto T., S. S Kakehata, T. Saito, H. Saito and N Akaike (1994). Cisplatin blocks voltage-dependent calcium current in dissociated outer hair cells of the guinea-pig cochlea. Brain Res. 648, 296-298.
38. Zoli W., A Flamigni, G. L. Frassineti, P. Bajorko, F. De Paola, C. Milandri, D. Amadori and A. Gasperi (1995). In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers. Breast Cancer Res Treat. 34, 63-69.